Current Cancer Drug Targets

Papers
(The H4-Index of Current Cancer Drug Targets is 17. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
LMNB1/CDKN1A Signaling Regulates the Cell Cycle and Promotes Hepatocellular Carcinoma Progression98
Immune Checkpoint Inhibitors for Advanced Biliary Tract Cancer48
Development of Chromatin Regulator-related Molecular Subtypes and a Signature to Predict Prognosis and Immunotherapeutic Response in Head and Neck Squamous Cell Carcinoma40
Expression, Prognostic Value, and Immune Infiltration of MTHFD Family in Bladder Cancer40
Knockdown of PRKD2 Enhances Chemotherapy Sensitivity in Cervical Cancer via the TP53/CDKN1A Pathway33
Artesunate overcomes lenvatinib resistance by inhibiting the STAT3/SLC25A27 pathway and promoting ferroptosis in hepatocellular carcinoma32
Etiology-based Molecular Characterization of Hepatocellular Carcinoma Reveals SQLE's Contribution to Immunosuppressive Microenvironment32
A Review on Patient-derived 3D Micro Cancer Approach for Drug Screen in Personalized Cancer Medicine28
Bioinformatics and Experimental Study Revealed LINC00982/ miR-183-5p/ABCA8 Axis Suppresses LUAD Progression22
DDX18 as a Prognostic Biomarker Associated with Pan-Cancer Immune Infiltration and Drug Sensitivity21
Combined RNAi of CTTN and FGF2 Modulates Cell Migration, Invasion and G1/S Transition of Hepatocellular Carcinoma through Ras/ERK Signaling Pathway19
A Pilot Study of Anlotinib as a Combination Treatment in Advanced Nasopharyngeal Carcinoma19
Micro-fragmented Fat Inhibits the Progression of Human Mesothelioma Xenografts in Mice19
The Therapeutic Potential of Urolithin A for Cancer Treatment and Prevention18
Leveraging a Disulfidptosis-related LncRNA Prognostic Signature to Indicate Immune Features and Drug Sensitivity of Gastric Cancer Based on Machine Learning18
Ectophosphatase Activity in Human Hepatocellular Carcinoma Huh7 Cells: Characterisation and Implications for the Tumour Microenvironment18
Silencing HEATR1 Rescues Cisplatin Resistance of Non-small Cell Lung Cancer by Inducing Ferroptosis via the p53/SAT1/ALOX15 Axis17
Precision Strategies for Normal Tissue Radiotoxicity: Biomarkers, AI, and Nanomedicine in Clinical Practice17
NRF2-Driven CARM1 Promotes Malignant Progression and Ferroptosis Resistance in Breast Cancer17
Spinal KCC2 Mediates the Modulation Effect of HDAC2 on Bone Cancer Pain in Rats17
0.097937107086182